A1RG34:BVMF
Argenx Se Bdr
R$215.88
0.00%
(0.00) 1D
Nov 10, 4:56:00 PM GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1RG34...
Open
R$215.75
High
R$216.00
Low
R$215.45
Mkt. cap
60.41B
Avg. vol.
38.00
Volume
270.00
52-wk high
R$216.00
52-wk low
R$143.22
Shares outstanding
62.89M
No. of employees
2K
Open
R$215.75
High
R$216.00
Low
R$215.45
Mkt. cap
60.41B
Avg. vol.
38.00
Volume
270.00
52-wk high
R$216.00
52-wk low
R$143.22
Shares outstanding
62.89M
No. of employees
2K
News stories
From web sources and news partners
Yahoo Finance
·
2 hours ago
argenx (ENXTBR:ARGX) Stock May Look Fully Priced Despite Its $1.15B Deal
Investing.com
·
5 hours ago
argenx at 3rd Annual Guggenheim Healthcare Innovation Conference: growth broadens
The Motley Fool
·
1 day ago
3 Reasons Argenx Could Be a Top Biotech Stock for the Next Decade
Belga Share
·
1 day ago
Argenx acquires US biotech company Unnatural Products
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About Argenx Se Bdr
CEO-
Employees1.86K
FoundedApr 25, 2008
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteargenx.com